The Promise of Senolytics to Treat Aging

Atria.org / Health Education / The Promise of Senolytics to Treat Aging

Dr. James Kirkland dives into the science of cellular senescence and how senolytic drugs could revolutionize aging by clearing harmful cells that drive age-related diseases. He highlights their potential to extend healthspan and tackle the broader challenges of an aging society.

About the episode:

In this episode, renowned aging researcher Dr. James L. Kirkland discusses cutting-edge research on cellular senescence and senolytics in aging. He explains how senescent cells accumulate over time, accelerating aging and contributing to age-related diseases. Dr. Kirkland highlights the potential of senolytic drugs to selectively eliminate these cells, potentially delaying or preventing age-related conditions such as osteoarthritis, Alzheimer's disease, and even the impact of coronavirus infections. The episode explores challenges with senolytic therapies and how senolytic research could extend healthspan and potentially address the societal challenges of an aging population.

About the series:

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.

Connect with us.

Thank you! We’ll be in touch shortly.